Detalles de la búsqueda
1.
Prevention of new osteitis on magnetic resonance imaging in patients with early axial spondyloarthritis during 3 years of continuous treatment with etanercept: data of the ESTHER trial.
Rheumatology (Oxford)
; 54(2): 257-61, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25140041
2.
Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15â mg may be overcome with subcutaneous administration.
Ann Rheum Dis
; 73(8): 1549-51, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24728329
3.
Nearly pain-free self-administration of subcutaneous methotrexate with an autoinjector: results of a phase 2 clinical trial in patients with rheumatoid arthritis who have functional limitations.
J Clin Rheumatol
; 20(5): 256-60, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25036562
4.
Active inflammation and structural change in early active axial spondyloarthritis as detected by whole-body MRI.
Ann Rheum Dis
; 72(6): 967-73, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22736088
5.
Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.
Ann Rheum Dis
; 72(6): 823-5, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23172749
6.
Combination etanercept and methotrexate provides better disease control in very early (<=4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study.
Ann Rheum Dis
; 71(6): 989-92, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22402142
7.
Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial.
Ann Rheum Dis
; 71(7): 1212-5, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22440819
8.
Does achieving clinical response prevent work stoppage or work absence among employed patients with early rheumatoid arthritis?
Rheumatology (Oxford)
; 51(2): 270-4, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21719418
9.
Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial.
Arthritis Rheum
; 63(6): 1543-51, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21630245
10.
Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritis.
Rheumatol Int
; 32(6): 1511-9, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21327436
11.
Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis: results from a large Japanese postmarketing surveillance study.
Rheumatol Int
; 32(6): 1617-24, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21331576
12.
Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis.
Rheumatology (Oxford)
; 50(2): 401-9, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21059675
13.
Differences in biologic dose-escalation, non-biologic and steroid intensification among three anti-TNF agents: evidence from clinical practice.
Clin Exp Rheumatol
; 29(1): 26-34, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21345289
14.
Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis: a two-year, double-blind, randomized study.
Arthritis Rheum
; 62(3): 674-82, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20187135
15.
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis.
Mod Rheumatol
; 21(4): 343-51, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21264488
16.
Efficacy and safety of etanercept in children and adolescents aged > or = 8 years with severe plaque psoriasis.
Eur J Dermatol
; 20(3): 323-8, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20185386
17.
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.
Lancet
; 372(9636): 375-82, 2008 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-18635256
18.
Response to: 'is there a direct relationship between serum level of methotrexate and clinical efficacy and tolerability?' by Fleishman and Yazici.
Ann Rheum Dis
; 73(9): e55, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24962874
19.
The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study.
Rheumatology (Oxford)
; 48(10): 1283-9, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19690125
20.
Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: continuous versus interrupted treatment.
Value Health
; 11(3): 400-7, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18489665